Who is sponsoring NCT03311763?

NCT03311763 is sponsored by Stanford University.

What drugs are being tested in NCT03311763?

Interventions in NCT03311763: EIM Fitness Practitioners, Counseling and wearable device.

What condition does NCT03311763 study?

NCT03311763 studies Chronic Kidney Disease stage4, Chronic Kidney Disease Stage V, Physical Activity.

Is NCT03311763 still recruiting?

NCT03311763 is currently completed. Last updated 8 February 2022.

Last reviewed 2022-02-08 · How we verify

NCT03311763: EIM-CKD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exercise is Medicine for Patients With CKD

Completed NA Last updated 8 February 2022

What this trial tests

NA trial testing EIM Fitness Practitioners in Chronic Kidney Disease stage4 in 56 participants. Completed in 30 November 2021.

Timeline

16 April 2018

Primary endpoint
31 December 2020

30 November 2021

Quick facts

Lead sponsor	Stanford University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	56
Start date	16 April 2018
Primary completion	31 December 2020
Estimated completion	30 November 2021
Sites	2 locations across United States

Drugs / interventions tested

EIM Fitness Practitioners
Counseling and wearable device

Conditions studied

Chronic Kidney Disease stage4 — all drugs for Chronic Kidney Disease stage4 →
Chronic Kidney Disease Stage V — all drugs for Chronic Kidney Disease Stage V →
Physical Activity — all drugs for Physical Activity →

Sponsor

Stanford University

Who can join

Adults 30 to 80, any sex, with Chronic Kidney Disease stage4 or Chronic Kidney Disease Stage V. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators plan to integrate and tailor the existing Exercise is Medicine framework, an evidence-based multi-level intervention program developed by the American Society of Sports Medicine, for the care of patients with advanced chronic kidney disease. In this pilot randomized control trial, investigators will compare the effects and feasibility of two intervention arms designed to start and maintain physical activity in this high-risk population (Group 1: physical activity assessment, brief counseling session + physical activity wearable versus Group 2: Group 1 intervention components + referral to a free, community-based, EIM practitioner led group exercise program).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Physical activity promotion for patients transitioning to dialysis using the "Exercise is Medicine" framework: a multi-center randomized pragmatic trial (EIM-CKD trial) protocol.
Jagannathan R, Ziolkowski SL, Weber MB, Cobb J, et al · · 2018 · cited 12× · PMID 30208854 · DOI 10.1186/s12882-018-1032-0
Perceptions of physical activity and technology enabled exercise interventions among people with advanced chronic kidney disease: a qualitative study.
Weber MB, Ziolkowski S, Bootwala A, Bienvenida A, et al · · 2021 · cited 8× · PMID 34758729 · DOI 10.1186/s12882-021-02591-9
Group-Based Exercise in CKD Stage 3b to 4: A Randomized Clinical Trial.
Anand S, Ziolkowski SL, Bootwala A, Li J, et al · · 2021 · cited 7× · PMID 34939004 · DOI 10.1016/j.xkme.2021.04.022

Verify or expand the search:

Other recruiting trials for Chronic Kidney Disease stage4

Currently open trials in the same condition.

NCT07309094 — Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD · recruiting

Other Stanford University trials

Trials by the same sponsor.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03311763 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stanford University
Last refreshed: 8 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03311763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing